ArticleLiver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society2008

Tezosentan, a novel endothelin receptor antagonist, markedly reduces rat hepatic ischemia and reperfusion injury in three different models.

Douglas G Farmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.